Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1969 1
1970 3
1972 1
1983 1
1987 1
1988 1
1989 1
1990 1
1993 2
1994 2
1995 1
1996 4
1997 2
1998 2
2002 2
2003 1
2004 1
2005 6
2006 1
2008 3
2017 1
2018 2
2022 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators. Dahlöf B, et al. Among authors: kristinsson a. Lancet. 2005 Sep 10-16;366(9489):895-906. doi: 10.1016/S0140-6736(05)67185-1. Lancet. 2005. PMID: 16154016 Clinical Trial.
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators. Sever PS, et al. Among authors: kristinsson a. Lancet. 2003 Apr 5;361(9364):1149-58. doi: 10.1016/S0140-6736(03)12948-0. Lancet. 2003. PMID: 12686036 Clinical Trial.
Quantitative historical analysis uncovers a single dimension of complexity that structures global variation in human social organization.
Turchin P, Currie TE, Whitehouse H, François P, Feeney K, Mullins D, Hoyer D, Collins C, Grohmann S, Savage P, Mendel-Gleason G, Turner E, Dupeyron A, Cioni E, Reddish J, Levine J, Jordan G, Brandl E, Williams A, Cesaretti R, Krueger M, Ceccarelli A, Figliulo-Rosswurm J, Tuan PJ, Peregrine P, Marciniak A, Preiser-Kapeller J, Kradin N, Korotayev A, Palmisano A, Baker D, Bidmead J, Bol P, Christian D, Cook C, Covey A, Feinman G, Júlíusson ÁD, Kristinsson A, Miksic J, Mostern R, Petrie C, Rudiak-Gould P, Ter Haar B, Wallace V, Mair V, Xie L, Baines J, Bridges E, Manning J, Lockhart B, Bogaard A, Spencer C. Turchin P, et al. Among authors: kristinsson a. Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E144-E151. doi: 10.1073/pnas.1708800115. Epub 2017 Dec 21. Proc Natl Acad Sci U S A. 2018. PMID: 29269395 Free PMC article.
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
Hakonarson H, Thorvaldsson S, Helgadottir A, Gudbjartsson D, Zink F, Andresdottir M, Manolescu A, Arnar DO, Andersen K, Sigurdsson A, Thorgeirsson G, Jonsson A, Agnarsson U, Bjornsdottir H, Gottskalksson G, Einarsson A, Gudmundsdottir H, Adalsteinsdottir AE, Gudmundsson K, Kristjansson K, Hardarson T, Kristinsson A, Topol EJ, Gulcher J, Kong A, Gurney M, Thorgeirsson G, Stefansson K. Hakonarson H, et al. Among authors: kristinsson a. JAMA. 2005 May 11;293(18):2245-56. doi: 10.1001/jama.293.18.2245. JAMA. 2005. PMID: 15886380 Clinical Trial.
44 results